Market News

Masters Capital Management Llc Increased Credit Suisse Group (Call) (CS) Stake by $17.00 Million; Aevi Genomic Medicine (GNMX) Shorts Up By 5.83%

Aevi Genomic Medicine Incorporated (NASDAQ:GNMX) had an increase of 5.83% in short interest. GNMX’s SI was 299,600 shares in February as released by FINRA. Its up 5.83% from 283,100 shares previously. With 458,600 avg volume, 1 days are for Aevi Genomic Medicine Incorporated (NASDAQ:GNMX)’s short sellers to cover GNMX’s short positions. The SI to Aevi Genomic Medicine Incorporated’s float is 1.3%. The stock increased 0.45% or $0.01 during the last trading session, reaching $2.24. About 85,314 shares traded. Aevi Genomic Medicine, Inc. (NASDAQ:GNMX) has declined 73.36% since February 17, 2017 and is downtrending. It has underperformed by 90.06% the S&P500.

Masters Capital Management Llc increased Credit Suisse Group (Call) (NYSE:CS) stake by 50% reported in 2017Q4 SEC filing. Masters Capital Management Llc acquired 1.00 million shares as Credit Suisse Group (Call) (NYSE:CS)’s stock declined 6.87%. The Masters Capital Management Llc holds 3.00M shares with $53.55 million value, up from 2.00M last quarter. Credit Suisse Group (Call) now has $45.25 billion valuation. The stock increased 0.21% or $0.04 during the last trading session, reaching $18.78. About 2.21 million shares traded. Credit Suisse Group AG (NYSE:CS) has risen 6.69% since February 17, 2017 and is uptrending. It has underperformed by 10.01% the S&P500.

Masters Capital Management Llc decreased Fireeye Inc (Call) (NASDAQ:FEYE) stake by 1.00M shares to 1.00M valued at $14.20 million in 2017Q4. It also reduced Verizon Communications Inc (Call) (NYSE:VZ) stake by 1.01M shares and now owns 1.00M shares. Metlife Inc (Call) (NYSE:MET) was reduced too.

Among 12 analysts covering Credit Suisse Group Ag (NYSE:CS), 9 have Buy rating, 1 Sell and 2 Hold. Therefore 75% are positive. Credit Suisse Group Ag had 24 analyst reports since July 28, 2015 according to SRatingsIntel. As per Tuesday, January 16, the company rating was initiated by Barclays Capital. Macquarie Research downgraded Credit Suisse Group AG (NYSE:CS) on Friday, January 13 to “Underperform” rating. As per Tuesday, September 12, the company rating was upgraded by Societe Generale. JP Morgan initiated Credit Suisse Group AG (NYSE:CS) on Monday, June 26 with “Overweight” rating. Morgan Stanley upgraded the stock to “Overweight” rating in Friday, February 17 report. As per Thursday, February 15, the company rating was upgraded by Societe Generale. The company was upgraded on Wednesday, August 26 by Vetr. Macquarie Research upgraded Credit Suisse Group AG (NYSE:CS) on Wednesday, November 15 to “Neutral” rating. The rating was maintained by Benchmark with “Buy” on Friday, January 22. The firm earned “Buy” rating on Monday, November 14 by Bank of America.

Credit Suisse Group AG, together with its subsidiaries, provides various financial services worldwide. The company has market cap of $45.25 billion. It operates through Swiss Universal Bank, International Wealth Management, Asia Pacific, Global Markets, and Investment Banking & Capital Markets divisions. It currently has negative earnings. The firm offers advisory and financial solutions, such as structured advisory, investment advisory, discretionary asset management, mergers and acquisitions transactions, corporate sales and restructurings, divestitures, takeover defense strategies, equity and fixed income sales, trading, debt and equity securities, spin-offs, debt and equity underwritings, private placements, and derivative products, as well as proprietary and third-party services and products.

Leave a Reply

Your email address will not be published. Required fields are marked *